![](https://endpts.com/wp-content/uploads/2022/10/Ravi-Srinivasan.jpg)
Ravi Srinivasan, i2o Therapeutics CEO
J&J and Sanofi-partnered oral delivery biotech raises $26M on latest offering
According to an SEC filing Tuesday, i2o Therapeutics raised $26 million in a private stock offering.
The Harvard spinout started out …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.